Joshua Oyster

Ninth Circuit Appeal May Significantly Affect FDA's Authority To Regulate Stem Cell Clinics

Podcast: Non-binding Guidance: The Regulatory Landscape For Drug Compounding—10 Years After The NECC Outbreak

Is Your Clinical Decision Support Software A Medical Device? Final Guidance Details FDA's Latest Thinking

Congress Enacts Clean Reauthorization Of FDA User Fees, Leaving Uncertain Future For Important Policy Reforms